Modular Assembly of Bioconjugates Enabled by a Pyridine‐Based Chemoselective Sequential Conjugation Platform

X Xiaobo Dang (Key Laboratory of Preclinical Study for New Drugs of Gansu Province School of Basic Medical Sciences Lanzhou University Lanzhou China) C Chenyang Zhang (Department of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University) J Jinlong Shang (Key Laboratory of Preclinical Study for New Drugs of Gansu Province School of Basic Medical Sciences Lanzhou University Lanzhou China) Z Zongtao Zhao (Key Laboratory of Preclinical Study for New Drugs of Gansu Province School of Basic Medical Sciences Lanzhou University Lanzhou China) C Chao Wang Z Zhaoqing Xu (Key Laboratory of Preclinical Study for New Drugs of Gansu Province School of Basic Medical Sciences Lanzhou University Lanzhou China)

Abstract

ABSTRACT Site‐selective Cys bioconjugation is central to chemical biology and therapeutic development. Owing to the widespread availability of amine‐containing building blocks, the modular assembly of alkylamines and Cys holds significant promise for diverse applications. However, existing strategies often suffer from reversible linkages, stereochemical heterogeneity, or limited modularity. Here we report a programmable pyridine‐based chemoselective sequential conjugation platform that integrates a thianthrenium leaving group and a fluorine handle on a single pyridine scaffold, enabling sequential, orthogonal coupling of alkylamines and Cys to form non‐chiral, stable aryl‐Cys linkages. The reaction exhibits exceptional functional group compatibility and high chemoselectivity in both the alkylamine‐ and thiol‐conjugation steps. The platform supports late‐stage peptide diversification and stapling, protein functionalization, and streamlined construction of a HER2‐targeting ADC (MRG002) analog with a tunable drug‐to‐antibody ratio. The resulting ADC shows slightly enhanced cytotoxicity in HER2‐positive cells, comparable activity in antigen‐negative controls, and markedly improved payload retention in human serum.

Article Details

Volume / Issue Vol. 1, Issue 1
Published July 08, 2026
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (6)

X

Xiaobo Dang

Key Laboratory of Preclinical Study for New Drugs of Gansu Province School of Basic Medical Sciences Lanzhou University Lanzhou China

C

Chenyang Zhang

Department of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University

J

Jinlong Shang

Key Laboratory of Preclinical Study for New Drugs of Gansu Province School of Basic Medical Sciences Lanzhou University Lanzhou China

Z

Zongtao Zhao

Key Laboratory of Preclinical Study for New Drugs of Gansu Province School of Basic Medical Sciences Lanzhou University Lanzhou China

C

Chao Wang

Z

Zhaoqing Xu

Key Laboratory of Preclinical Study for New Drugs of Gansu Province School of Basic Medical Sciences Lanzhou University Lanzhou China